EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status

Karla Vagnerová, Tomáš Hudcovic, Martin Vodička, Peter Ergang, Petra Klusoňová, Petra Petr Hermanová, Dagmar Šrůtková, Jiří Pácha

Frontiers in Pharmacology · 26.03.2024 · 15

DOI: 10.3389/fphar.2024.1341333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 26.03.2024. Verfasst von Karla Vagnerová und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology, Czech Academy of Sciences, Prague, Czechia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Butyrate, a metabolite produced by gut bacteria, has demonstrated beneficial effects in the colon and has been used to treat inflammatory bowel diseases. However, the mechanism by which butyrate operates remains incompletely understood. Given that oral butyrate can exert either a direct impact on the gut mucosa or an indirect influence through its interaction with the gut microbiome, this study aimed to investigate three key aspects: (1) whether oral intake of butyrate modulates the expression of genes encoding short-chain fatty acid (SCFA) transporters ( Slc16a1 , Slc16a3 , Slc16a4 , Slc5a8 , Abcg2 ) and receptors ( Hcar2 , Ffar2 , Ffar3 , Olfr78 , Olfr558 ) in the colon, (2) the potential involvement of gut microbiota in this modulation, and (3) the impact of oral butyrate on the expression of colonic SCFA transporters and receptors during colonic inflammation. Specific pathogen-free (SPF) and germ-free (GF) mice with or without DSS-induced inflammation were provided with either water or a 0.5% sodium butyrate solution. The findings revealed that butyrate decreased the expression of Slc16a1 , Slc5a8 , and Hcar2 in SPF but not in GF mice, while it increased the expression of Slc16a3 in GF and the efflux pump Abcg2 in both GF and SPF animals. Moreover, the presence of microbiota was associated with the upregulation of Hcar2 , Ffar2, and Ffar3 expression and the downregulation of Slc16a3 . Interestingly, the challenge with DSS did not alter the expression of SCFA transporters, regardless of the presence or absence of microbiota, and the effect of butyrate on the transporter expression in SPF mice remained unaffected by DSS. The expression of SCFA receptors was only partially affected by DSS. Our results indicate that (1) consuming a relatively low concentration of butyrate can influence the expression of colonic SCFA transporters and receptors, with their expression being modulated by the gut microbiota, (2) the effect of butyrate does not appear to result from direct substrate-induced regulation but rather reflects an indirect effect associated with the gut microbiome, and (3) acute colon inflammation does not lead to significant changes in the transcriptional regulation of most SCFA transporters and receptors, with the effect of butyrate in the inflamed colon remaining intact.

Schlagwörter

Stichwörter der Autor:innen

butyratebutyrate receptorsbutyrate transporterscolitisdextran sulfategerm-free (GF)microbiotashort chain fatty acid (SCFA)

Autor:innen und Institutionen

  • Institute of Physiology, Czech Academy of Sciences, Prague, Czechia.
  • Institute of Microbiology, Czech Academy of Sciences, Nový Hrádek, Czechia.
  • Department of Physiology, Faculty of Science, Charles University, Prague, Czechia.

Zitieren

APA

Vagnerová, K., Hudcovic, T., Vodička, M., Ergang, P., Klusoňová, P., Petr Hermanová, P., Šrůtková, D., & Pácha, J. (2024). The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1341333

Vancouver

Vagnerová K, Hudcovic T, Vodička M, Ergang P, Klusoňová P, Petr Hermanová P, et al. The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1341333

BibTeX
@article{Vagnerov2024,
  author = {Vagnerová, Karla and Hudcovic, Tomáš and Vodička, Martin and Ergang, Peter and Klusoňová, Petra and Petr Hermanová, Petra and Šrůtková, Dagmar and Pácha, Jiří},
  title = {The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1341333}
}
Kostenlos starten →